Deepak Srivastava, M.D., is the Director of the Gladstone Institute of Cardiovascular Disease and the Roddenberry Stem Cell Center at Gladstone, and is also a Professor at the University of California, San Francisco (UCSF) Medical Center.
Dr. Srivastava received his B.S. from Rice University, M.D. from University of Texas, trained in pediatrics at UCSF, and in pediatric cardiology at Harvard Medical School.
Dr. Srivastava’s laboratory discovered genetic bases for cardiac septal and valve defects and revealed complex signaling, transcriptional, and translational networks that regulate progenitor cells to adopt a cardiac cell fate and subsequently fashion a functioning heart. He has leveraged this knowledge to reprogram fibroblasts directly into cardiomyocyte-like cells for regenerative purposes. Dr. Srivastava is a member of the American Academy of Arts and Sciences and the National Academy of Medicine.